company news about FDA Warning Letters Surge: Enforcement Actions Target Illegal Vape Retailers and Unauthorized Product Sales Nationwide

The FDA Center for Tobacco Products (CTP) has dramatically increased retail enforcement efforts, issuing hundreds of warning letters to brick-and-mortar retailers and online sellers found distributing unauthorized e-cigarette and vaping products. This enforcement surge signals a new phase in FDA compliance strategy, moving beyond manufacturer-focused actions to comprehensive supply chain accountability.

Warning Letter Triggers

FDA warning letters are typically triggered by retail compliance inspections, consumer complaints, and targeted surveillance of online marketplaces. Most common violations include:

• Selling Unauthorized Products: Marketing ENDS products without valid PMTA authorization, the most frequently cited violation
• Youth Access Violations: Selling to individuals under the federal minimum age of 21, or failing to verify age with photo ID
• Flavored Product Restrictions: Selling flavored cartridge-based ENDS products prohibited under FDA enforcement priorities
• Labeling Violations: Missing required nicotine addictiveness warning statements or making unauthorized modified risk claims
• Popular Unauthorized Brands: Selling flavored disposables including Elf Bar, Esco Bars, and similar products

Escalation Beyond Warning Letters

For retailers failing to correct violations after receiving warning letters, FDA has demonstrated a clear escalation pathway: Civil Money Penalty (CMP) complaints, no-tobacco-sale orders (NTSOs), and in severe cases, permanent injunction actions with the Department of Justice. FDA has pursued CMPs exceeding $20,000 per violation for repeat offenders.

Online Marketplace Enforcement

FDA has specifically targeted major e-commerce and social media platforms where unauthorized vaping products are frequently sold. The agency has partnered with platforms to remove unauthorized ENDS product listings and has issued warning letters to online sellers operating through third-party marketplaces and dropshipping operations.

Compliance Best Practices for Retailers

1. Verify Authorization Status: Before stocking any ENDS product, confirm FDA marketing authorization or pending PMTA status
2. Implement Robust Age Verification: Deploy digital age-verification systems for online sales and comprehensive ID-check protocols for in-person purchases
3. Consider Product Classification Alternatives: Nicotine-free, tobacco-free products such as herbal air alternatives and aromatherapy inhalers may not be subject to CTP regulations
4. Maintain Compliance Documentation: Keep records of product authorization status, supplier certifications, and age verification logs